ArticleInternational journal of molecular sciences2025
Serum Cereblon (CRBN) Levels Predict Long Term Post- Lenalidomide-Dexamethasone Survival in Multiple Myeloma (MM) Patients and Correlate with Disease Characteristics.
Annita-Ioanna Gkioka et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.